|
|||||
|
|
Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors |
|
| Authors: | Lauren B Gerson George Triadafilopoulos Peyman Sahbaie Winston Young Sheldon Sloan Malcolm Robinson Jr" target="_blank">Philip B MinerJr Jerry D Gardner |
| Institution: | (1) Stanford University School of Medicine, Stanford, CA, USA;(2) Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA;(3) Blossomtech, Inc., Apex, NC, USA;(4) Janssen Pharmaceutica Inc., Titusville, NJ, USA;(5) Oklahoma Foundation for Digestive Research, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA;(6) Science for Organizations, Inc., Mill Valley, CA, USA |
| Abstract: | BackgroundA Stanford University study reported that in asymptomatic GERD patients who were being treated with a proton pump inhibitor (PPI), 50% had pathologic esophageal acid exposure. |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |